---All---
  • ---All---
  • Accession
  • Catalog #

GCNT2 Antibody (Center)Peptide Affinity Purified Rabbit Polyclonal Antibody (Pab)

Country
United States
Australia Austria Belgium Brazil Bulgaria Canada China Croatia Cyprus Czech Republic Denmark Estonia Finland France Germany Greece Hungary Iceland India Indonesia Ireland Israel Italy Japan Korea Latvia Lithuania Luxembourg Macedonia Malaysia Malta Netherlands Norway Pakistan Poland Portugal Romania Serbia Singapore Slovakia Slovenia Spain Sweden Switzerland Taiwan Turkey United Kingdom United States Vietnam Others
Ordering Information
Catalog # Size Availability Price  
AP18452c 0.1 mg 400 ul In Stock $ 255.00 Add to cart
AP18452c-ev20 20 ug 100 ul In Stock $ 95.00 Add to cart
  • Specification
  • Citiations : 0
  • Reviews
  • Protocols
  • Backgrounds

GCNT2 Antibody (Center) - Product info

ApplicationWB
  • Applications Legend:
  • W=Western Blotting
  • IP=Immunoprecipitation
  • IHC-P=Immunohistochemistry (Paraffin)
  • IF-IC=Immunofluorescence (Immunocytochemistry)
  • F=Flow Cytometry
Primary AccessionQ8N0V5
Other AccessionNP_663624.1
ReactivityHuman
Concentration0.25 mg/ml
IsotypeRabbit Ig
Calculated MW45873 Da

GCNT2 Antibody (Center) - Additional info

Gene ID 2651
Other Names
GCNT2; GCNT5; II; NACGT1; N-acetyllactosaminide beta-1, 6-N-acetylglucosaminyl-transferase, isoform A; I-branching enzyme; IGNT
Target/Specificity
This GCNT2 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 212-240 amino acids from the Central region of human GCNT2.
Dilution
WB~~1:100~500
Format
Purified polyclonal antibody supplied in PBS with 0.09% (W/V) sodium azide. This antibody is purified through a protein A column, followed by peptide affinity purification.
Storage
Maintain refrigerated at 2-8°C for up to 6 months. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Precautions
GCNT2 Antibody (Center) is for research use only and not for use in diagnostic or therapeutic procedures.

GCNT2 Antibody (Center) - Protein Information

Name GCNT2
Synonyms GCNT5, II, NACGT1
Function
Branching enzyme that converts linear into branched poly-N-acetyllactosaminoglycans. Introduces the blood group I antigen during embryonic development. It is closely associated with the development and maturation of erythroid cells. The expression of the blood group I antigen in erythrocytes is determined by isoform C
Cellular Location
Golgi apparatus membrane; Single-pass type II membrane protein (By similarity)
Tissue Location
Isoform B is expressed in lens epithelium cells. Isoform C is expressed in reticulocytes

GCNT2 Antibody (Center) - Related products

AP10215b: GCNT2 Antibody (C-term)

AP18452c: GCNT2 Antibody (Center)

DC14682: Human GCNT2 cDNA Clone

LY12707a: GCNT2 Over-expression Lysate

BP10215b: GCNT2 Antibody (C-term) Blocking peptide

Abgent welcomes feedback from its customers.

If you have used an Abgent product and would like to share how it has performed, please click on the
"Submit Review" button and provide the requested information. Our staff will examine and post your
review and contact you if needed.

If you have any additional inquiries please email technical services at tech@abgent.com.

Thank you for your support.


Submit

Provided below are standard protocols that you may find useful for product applications.

BACKGROUND

This gene encodes the enzyme responsible for formation of the blood group I antigen. The i and I antigens are distinguished by linear and branched poly-N-acetyllactosaminoglycans, respectively. The encoded protein is the I-branching enzyme, a beta-1,6-N-acetylglucosaminyltransferase responsible for the conversion of fetal i antigen to adult I antigen in erythrocytes during embryonic development. Mutations in this gene have been associated with adult i blood group phenotype. Alternatively spliced transcript variants encoding different isoforms have been described.

REFERENCES

Twu, Y.C., et al. Blood 110(13):4526-4534(2007) Wang, L., et al. Biochem. Biophys. Res. Commun. 331(4):958-963(2005) Pras, E., et al. Invest. Ophthalmol. Vis. Sci. 45(6):1940-1945(2004) Inaba, N., et al. Blood 101(7):2870-2876(2003) Yu, L.C., et al. Blood 101(6):2081-2088(2003)